Document Detail


Systolic hypertension in older persons.
MedLine Citation:
PMID:  15339901     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure emphasizes the importance of systolic hypertension (SH), defined as systolic blood pressure (SBP) of at least 140 mm Hg and diastolic blood pressure of less than 90 mm Hg, in older persons (> or =60 years).
OBJECTIVE: To systematically review the literature on clinical management of SH in older persons.
DATA SOURCES: We performed a MEDLINE search of English-language literature from 1966-2004 to identify reports about SH in older persons, with particular emphasis on data from randomized clinical trials.
STUDY SELECTION AND DATA EXTRACTION: We selected 1064 studies by using the search terms hypertension combined with the terms systole (or systolic) and aged.
DATA SYNTHESIS: There is strong evidence from clinical trials to support the treatment of SH in older persons with SBP of at least 160 mm Hg. Large-scale trials to assess the value of antihypertensive therapy for older patients with SBP of 140 to 159 mm Hg have not been performed, and recommendations to treat these patients are based on observational studies that show a graded relationship of cardiovascular risk with increasing SBP. The studies most strongly support the use of thiazide diuretics and long-acting calcium channel blockers as first-line therapy to treat SH.
CONCLUSIONS: Treatment of SH in older patients with SBP of at least 160 mm Hg is supported by strong evidence. The evidence available to support treatment of patients to the level of 140 mm Hg or those with baseline SBP of 140 to 159 mm Hg is less strong; thus, these treatment decisions should be more sensitive to patient preferences and tolerance of therapy.
Authors:
Sarwat I Chaudhry; Harlan M Krumholz; JoAnne Micale Foody
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review    
Journal Detail:
Title:  JAMA     Volume:  292     ISSN:  1538-3598     ISO Abbreviation:  JAMA     Publication Date:  2004 Sep 
Date Detail:
Created Date:  2004-09-01     Completed Date:  2004-09-06     Revised Date:  2014-09-17    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1074-80     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Antihypertensive Agents / therapeutic use
Humans
Hypertension / diagnosis,  therapy*
Grant Support
ID/Acronym/Agency:
K08-AG20623-01/AG/NIA NIH HHS; K23 AG030986/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Antihypertensive Agents
Comments/Corrections
Comment In:
JAMA. 2004 Nov 24;292(20):2465-6; author reply 2466   [PMID:  15562117 ]
JAMA. 2004 Nov 24;292(20):2465; author reply 2466   [PMID:  15562118 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Next Document:  The subunit b dimer of the FOF1-ATP synthase: interaction with F1-ATPase as deduced by site-specific...